Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/89/45/15/894515df-8cf9-1503-7f86-69eb52e6baea/mza_1769051247888600121.jpg/600x600bb.jpg

The Studio at Kendall Square

BiotechTV

20 episodes

1 week ago

The Studio at Kendall Square is a video podcast studio built by BiotechTV and MassBio at MassBio's headquarters in Tech Square at Kendall Square. It is a platform for the Boston biotech community to use and have your podcast discussions recorded in-person and then broadcast on BiotechTV. The studio will give voice to the vast network of experts who live in and around 'The Most Innovative Square Mile on the Planet'.

Life Sciences

Science

RSS

All content for The Studio at Kendall Square is the property of BiotechTV and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43071135/43071135-1739798930577-a3506be8e4eaf.jpg

Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech

The Studio at Kendall Square

15 minutes 3 seconds

1 year ago

Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech

Biotech industry veteran Harvery Berger talks about his company's job at hand to translate the science of ferroptosis into therapies. Plus, a warning about the currently very difficult funding environment for preclinical and other early stage companies in the sector.